Search Results - V. Strulev
- Showing 1 - 6 results of 6
-
1
P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE L... by H. Einsele, P. Moreau, M. Delforge, N. W. van de Donk, F. Ghilotti, J. Diels, A. Elsada, V. Strulev, L. Pei, R. Kobos, J. Smit, M. Slavcev, K. Weisel, M.-V. Mateos
Published in HemaSphere (2022-06-01)Get full text
Article -
2
P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPO... by K. Weisel, M.-V. Mateos, L. Vincent, T. Martin, J. G. Berdeja, A. Jakubowiak, S. Jagannath, Y. Lin, P. Thilakarathne, F. Ghilotti, J. Diels, B. Haefliger, C. Hague, A. Gonzalez, J. M. Schecter, K. S. Gries, V. Strulev, T. Nesheiwat, L. Pacaud, H. Einsele, P. Moreau
Published in HemaSphere (2022-06-01)Get full text
Article -
3
P960: HEALTH-RELATED QUALITY OF LIFE IN THE LOCOMMOTION STUDY OF REAL-LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA by M. Delforge, P. Moreau, H. Einsele, V. De Stefano, J. Lindsey-Hill, L. Vincent, S. Mangiacavalli, A. Perrot, E. Ocio, S. ten Seldam, E. I. ’. Groen-Damen, M. Semerjian, V. Strulev, J. M. Schecter, T. Roccia, K. S. Gries, T. Nesheiwat, R. Wapenaar, M.-V. Mateos, K. Weisel
Published in HemaSphere (2022-06-01)Get full text
Article -
4
P958: REAL-LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSES FROM THE LOCOMMOTION STUDY by H. Einsele, P. Moreau, V. De Stefano, D. Dytfeld, E. Angelucci, R. Benjamin, H. Goldschmidt, N. W. van de Donk, B. Besemer, C. Scheid, R. Vij, E. I. ’. Groen-Damen, M. Semerjian, V. Strulev, J. M. Schecter, T. Roccia, T. Nesheiwat, R. Wapenaar, K. Weisel, M.-V. Mateos
Published in HemaSphere (2022-06-01)Get full text
Article -
5
C004 | REALITEC: A MULTI-COUNTRY OBSERVATIONAL RETROSPECTIVE STUDY OF TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA OUTSIDE OF CLINICAL TRIALS by C. Liberatore, M.C. Da Vià, K.M. Kortüm, K. Uttervall, R. Popat, S.L. Farmer, B. Kishore, C. Jacquet, M. Casanova, M. Hansson, K. Weisel, H. Magen, C. Toftmann Hansen, M.E. Gatt, T. Shragai, T. De Soto Alvarez, M. Streetly, M-S. Raab, S. Manier, J. Aegesen, R. Takchi, P. Hu, D. Santra, V. Strulev, E. Rubio-Azpeitia, C. Albrecht, A. Perrot, M. Cavo
Published in Haematologica (2025-09-01)Get full text
Article -
6
C062 | FIRST RESULTS FROM REALITAL: A EUROPEAN MULTICOUNTRY OBSERVATIONAL RETROSPECTIVE STUDY OF TALQUETAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA OUTSIDE OF CLINIC... by M.C. Da Vià, K.M. Kortüm, R. Popat, K. Uttervall, V. Mykytiv, H. Magen, E. Antonioli, C. Liberatore, E. Zamagni, M. Hansson, M. Musso, J. Krawczyk, T. Shragai, K. Weisel, R. Teipel, D. Knut-Bojanowska, C. Toftmann Hansen, P. Hayden, M. Haenel, M-S. Raab, F. Pane, S. Leeth Farmer, M.E. Gatt, V. De Stefano, B. Kishore, S. Strifler, R. Takchi, P. Hu, D. Santra, V. Strulev, E. Rubio-Azpeitia, E. Aeby, K. Subrt, C. Albrecht, N. Martin Suñe, A. Perrot
Published in Haematologica (2025-09-01)Get full text
Article
